Evidence map›Paper›PMID 42019937›Full record

Trial reportJournal of physical activity & health2026

Understanding the Effects of Cancer-Related Factors on the Association Between Physical Activity and Quality of Life in Breast Cancer Survivors.

Erica Schleicher, Wendy Demark-Wahnefried, Gregory Pavela, Kevin Fontaine, Nataliya Ivankova, Maria Pisu, Michelle Y Martin, Yu-Mei Schoenberger-Godwin, Robert A Oster, Kelly Marie Kenzik and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of physical activity & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Erica SchleicherDivision of Hematology Oncology, School of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.ORCID 0000-0003-4051-0622
Wendy Demark-WahnefriedDepartment of Nutrition Sciences, School of Health Professions, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-5241-932X
Gregory PavelaDepartment of Health Behavior, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-5750-4021
Kevin FontaineDepartment of Health Behavior, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-2807-6440
Nataliya IvankovaDepartment of Health Services Administration, School of Health Professions, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-5742-7035
Maria PisuDivision of General Internal Medicine and Population Science, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0001-9329-3268
Michelle Y MartinDepartment of Preventive Medicine, College of Medicine-Memphis, The University of Tennessee Health Science Center, Memphis, TN, USA.ORCID 0000-0003-0954-3223
Yu-Mei Schoenberger-GodwinObesity Health Disparities Research Center, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-7877-7819
Robert A OsterDivision of General Internal Medicine and Population Science, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-2247-8596
Kelly Marie KenzikDivision of Hematology and Oncology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-6402-8446
Laura Q RogersDivision of General Internal Medicine and Population Science, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0003-4216-8381

Funding

Recruitment and Biostatistics (R & B) SRC Core Co-Leads: Pisu and OsterP01CA229997 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Wendy Demark-Wahnefried, LAURA Q ROGERS · 2018 to 2026
$17.1M
UAB Cancer Prevention and Control Training Program (T32)T32CA047888 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Ritu Aneja, Ellen Mary Lavoie Smith · 2018 to 2026
$3.2M
NCI NIH HHS P01 CA229997NCI NIH HHS T32 CA047888
6 · The paper itself

Abstract

backgroundBreast cancer survivors often experience physical and mental side effects posttreatment, compromising their quality of life (QoL). The increasing number of survivors coping with long-term side effects creates public health concerns, emphasizing the need for supportive interventions. Although physical activity (PA) benefits cancer survivors, few studies examine the effect that cancer-related factors have on the relationship between PA levels and QoL among breast cancer survivors. Understanding the associations that cancer-related factors may have on the QoL response to PA is crucial for developing effective interventions.

methodsBaseline data from 341 postprimary treatment breast cancer survivors enrolled in a web-based diet and/or exercise intervention randomized controlled trial were analyzed. PA measures included accelerometry and self-reported moderate to vigorous PA (MVPA). QoL was assessed using Patient-Reported Outcomes Measurement Information System (PROMIS) global QoL and EuroQOL-5D-5L questionnaires. Pearson correlation coefficient tests and multiple linear regression assessed associations between MVPA and QoL and whether cancer-related factors moderated these associations.

resultsThe EuroQOL-5D-5L QoL index (and 4 out of 5 domains) showed statistically significant associations with self-reported MVPA. PROMIS physical health was correlated with both MVPA measures. Survivors > 24 months postdiagnosis had stronger associations between accelerometry-measured MVPA levels and EuroQOL-5D-5 L QoL index (β = 0.0004, P = .003). Survivors receiving hormone therapy exhibited stronger associations between self-reported MVPA levels and PROMIS-physical health QoL domain compared with those not (β = 0.0121, P = .028).

conclusionGreater MVPA was modestly associated with better QoL, with stronger associations observed in survivors receiving hormone therapy or >24 months postdiagnosis. There are potential QoL benefits in implementing interventions immediately postdiagnosis and tailoring to treatment histories.

Indexed as

Breast NeoplasmsCancer SurvivorsExerciseQuality of LifeAccelerometryAdultAgedFemaleHumansMiddle AgedSurveys and Questionnairescancer treatment historyexercise oncologysurvivorship

Identifiers

PMID42019937
PMCPMC13367560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.